PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Internal Medicine10.3904/kjim.2016.4292018331228-229Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims databaseJi-Won Kim, Sang Gyu Kwak, Sung-Hoon Parkhttp://kjim.org/upload/kjim-2016-429.pdf, http://kjim.org/journal/view.php?doi=10.3904/kjim.2016.429, http://kjim.org/upload/kjim-2016-429.pdf
Value in Health10.1016/j.jval.2012.03.2722012154A49PMS83 Adherence and Uric Acid Goal Attainment with Urate Lowering Therapy in Patients with GoutN. Rashid, C.T. Cheetham, F. Niuhttp://api.elsevier.com/content/article/PII:S1098301512003373?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S1098301512003373?httpAccept=text/plain
The Korean Journal of Internal Medicine10.3904/kjim.2006.21.2.89200621289Effect of Fenofibrate in Combination with Urate Lowering Agents in Patients with GoutYou-Hyun Lee, Chan-Hee Lee, Jisoo Leehttp://synapse.koreamed.org/pdf/10.3904/kjim.2006.21.2.89, http://synapse.koreamed.org/DOIx.php?id=10.3904/kjim.2006.21.2.89
Value in Health10.1016/j.jval.2015.03.9022015183A155Long-Term Decrease In Gout Flare Rates Associated With Effective Urate Lowering TherapyK. Keltonhttps://api.elsevier.com/content/article/PII:S1098301515009596?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301515009596?httpAccept=text/plain
BMC Musculoskeletal Disorders10.1186/1471-2474-13-1742012131Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in goutNicola Dalbeth, Meaghan E House, Anne Horne, Keith J Petrie, Fiona M McQueen, William J Taylorhttp://link.springer.com/content/pdf/10.1186/1471-2474-13-174.pdf, http://link.springer.com/article/10.1186/1471-2474-13-174/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2474-13-174
Patient Preference and Adherence10.2147/ppa.s979272017Volume 11795-800Treatment approaches and adherence to urate-lowering therapy for patients with goutThanda Aung, Gihyun Myung, John FitzGeraldhttps://www.dovepress.com/getfile.php?fileID=36092, https://www.dovepress.com/getfile.php?fileID=36092
Nature Reviews Rheumatology10.1038/nrrheum.2013.120201399506-506Intensive urate-lowering therapy improves structural joint damage in patients with tophaceous goutJenny Bucklandhttp://www.nature.com/articles/nrrheum.2013.120.pdf, http://www.nature.com/articles/nrrheum.2013.120, http://www.nature.com/articles/nrrheum.2013.120.pdf
Current Rheumatology Reports10.1007/s11926-018-0760-22018208Predicting Response or Non-response to Urate-Lowering Therapy in Patients with GoutGarry G. Graham, Sophie L. Stocker, Diluk R.W. Kannangara, Richard O. Dayhttp://link.springer.com/article/10.1007/s11926-018-0760-2/fulltext.html, http://link.springer.com/content/pdf/10.1007/s11926-018-0760-2.pdf, http://link.springer.com/content/pdf/10.1007/s11926-018-0760-2.pdf
Joint Bone Spine10.1016/j.jbspin.2015.02.0212015826428-431Significance of the initiation time of urate-lowering therapy in gout patients: A retrospective researchXin Feng, Yao Li, Wei Gaohttps://api.elsevier.com/content/article/PII:S1297319X15001682?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1297319X15001682?httpAccept=text/plain
Joint Bone Spine10.1016/j.jbspin.2018.06.0012018Inpatient rheumatology consultation for gout flares and advice to initiate urate lowering treatment (ULT) in hospital discharge summary increases ULT prescription in primary careAneesa Kapadia, Abhishek Abhishekhttps://api.elsevier.com/content/article/PII:S1297319X18301258?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1297319X18301258?httpAccept=text/plain